Children’s Hospital Colorado Part of Phase 3 Trial of Vertex’s Potential Triple Combo CF Therapy

JULY 9, 2018

BY ALICE MELÃO

 

IN CYSTIC FIBROSIS, NEWS.

The Mike McMorris Cystic Fibrosis Research and Care Center, part of the Children’s Hospital Colorado, is one of the 82 clinical sites involved in the Phase 3 clinical trial that is assessing the efficacy of VX-659 in a triple combination with Symdeko (tezacaftor/ivacaftor and ivacaftor). The trial (NCT03447249) will test the triple combination in cystic fibrosis […] The post Children’s Hospital Colorado Part of Phase 3 Trial of Vertex’s Potential Triple Combo CF Therapy appeared first on Cystic Fibrosis News Today.

Read More